Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.93
Price to sales ratio
5.71

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3562
CHRS
Coherus Oncology, Inc. - Common Stock
1.43 USD-2.05%+1.42%-0.69%-11.18%220.94 M USD
3572
KROS
Keros Therapeutics, Inc. - common stock
10.90 USD-2.94%+0.37%+7.50%-27.81%216.12 M USD
3577
CRBP
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
11.10 USD-0.27%+8.29%+22.25%-33.13%214.69 M USD
3580
ANTX
AN2 Therapeutics, Inc. - Common Stock
5.67 USD-1.22%-2.07%+21.41%+410.81%213.96 M USD

Frequently asked questions about Voyager Therapeutics, Inc. Common Stock

What is the Voyager Therapeutics, Inc. Common Stock stock price today?

The current price of Voyager Therapeutics, Inc. Common Stock (VYGR) is 3.50. Over the past 24 hours, the stock has changed by +1.16%. Follow the VYGR chart for real-time price dynamics.

What is the stock ticker of Voyager Therapeutics, Inc. Common Stock?

Voyager Therapeutics, Inc. Common Stock trades under the ticker VYGR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Voyager Therapeutics, Inc. Common Stock stock going up?

VYGR has changed by +2.94% over the last week, +15.89% over the last month, and -24.73% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Voyager Therapeutics, Inc. Common Stock?

Voyager Therapeutics, Inc. Common Stock currently has a market capitalization of 215.66 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Voyager Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Voyager Therapeutics, Inc. Common Stock reported earnings of -0.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Voyager Therapeutics, Inc. Common Stock revenue for the last quarter?

Voyager Therapeutics, Inc. Common Stock reported quarterly revenue of 3.17 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Voyager Therapeutics, Inc. Common Stock net income for the last quarter?

Voyager Therapeutics, Inc. Common Stock reported net income of -24.47 M for the last quarter. The previous quarter showed -27.94 M, which means net income changed by +12.40%.

How many employees does Voyager Therapeutics, Inc. Common Stock have?

As of the latest available data, Voyager Therapeutics, Inc. Common Stock has 141 employees. Workforce size can provide additional context about the company's scale and operations.

What is Voyager Therapeutics, Inc. Common Stock EBITDA?

Voyager Therapeutics, Inc. Common Stock EBITDA is -25.73 M, and its EBITDA margin is -813.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Voyager Therapeutics, Inc. Common Stock stock?

You can buy Voyager Therapeutics, Inc. Common Stock (VYGR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Voyager Therapeutics, Inc. Common Stock stock?

Investing in Voyager Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VYGR chart and related analysis on metatrader.com as part of your research.

News